Covered recipient · General Payments record
JAMES PASTERNACK
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2019–2025
$1,954.29
- Reported across 98 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $307.65 | 18 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $226.15 | 15 |
| Tarsus Pharmaceuticals, Inc. | $55.65 | 2 |
| Alcon Vision LLC | $25.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.67 | 01/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203490015 | CMS |
| ABBVIE INC. | $20.78 | 02/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203490021 | CMS |
| ABBVIE INC. | $6.70 | 03/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203490026 | CMS |
| ABBVIE INC. | $6.66 | 04/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203490032 | CMS |
| ABBVIE INC. | $15.91 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203490041 | CMS |
| ABBVIE INC. | $7.79 | 06/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203490045 | CMS |
| ABBVIE INC. | $23.35 | 06/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203490052 | CMS |
| ABBVIE INC. | $9.75 | 07/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203490057 | CMS |
| ABBVIE INC. | $19.82 | 07/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203490062 | CMS |
| ABBVIE INC. | $14.61 | 08/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203490068 | CMS |
| ABBVIE INC. | $19.59 | 09/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203490075 | CMS |
| ABBVIE INC. | $33.03 | 09/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203490080 | CMS |
| ABBVIE INC. | $17.47 | 10/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203490087 | CMS |
| ABBVIE INC. | $8.58 | 11/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203490092 | CMS |
| ABBVIE INC. | $6.44 | 12/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203490098 | CMS |
| Alcon Vision LLC | $25.85 | 06/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207439930 | CMS |
| Tarsus Pharmaceuticals, Inc. | $25.39 | 01/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233892852 | CMS |
| Tarsus Pharmaceuticals, Inc. | $30.26 | 06/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233892854 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.